244580·Stock-Sector-Healthcare
KODEX BIO
Introduction
The KODEX BIO ETF seeks to provide investment results that, before expenses, correspond generally to the price and yield performance of the FnGuide Bio Index
Investment Points
An ETF that invests in stocks involved in the bio industry, which is regarded as the next-generation driver of economic growth globally, focusing on the rapidly progressing aging phenomenon due to life extension and low birth rates.
Benchmark Index
FnGuide Bio Index
Benchmark Index Description
Index composed of stocks that meet the following conditions:
1. Engaging in bio-related businesses through the parent company or subsidiaries.
2. Planning to engage in bio-related businesses through the parent company or subsidiaries in the future.
3. Entering the bio-related business through equity investment in bio ventures.
4. Benefiting from the growth of the bio industry in other ways.
※ Bio (Pharmaceutical) business includes companies engaged in biotechnology such as stem cells and natural resource-based new drug development. Companies engaged in healthcare, chemical pharmaceuticals, and veterinary pharmaceuticals are excluded.
5. Companies with a market capitalization of over 100 billion KRW among listed firms in the stock exchange or KOSDAQ that meet the above conditions.
Issuer
Samsung Asset Management
Brand
KODEX
Total Fee
0.45
Listing Date
2016-05-13
International Securities Code
KR7244580007
Market Information
Market Capitalization
147,230,400,000KRW
Transaction Amount
2,250,254,710KRW
Trading Volume
269,960
Shares Outstanding
17,760,000
NAV
8,367
52-Week High
9,405KRW
52-Week Low
7,055KRW